Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 24,575 | 6,702 | 1,954 | -21,958 | -14,943 |
| Depreciation Amortization | 879 | 748 | 1,643 | 11,995 | 5,496 |
| Income taxes - deferred | -21,254 | N/A | N/A | -93 | 38 |
| Accounts receivable | 2,895 | -3,466 | 227 | -133 | 2,148 |
| Accounts payable and accrued liabilities | -807 | 120 | 489 | -735 | -1,817 |
| Other Working Capital | 1,288 | -3,676 | -1,235 | -3,991 | -1,131 |
| Other Operating Activity | -1,745 | 4,218 | 711 | 7,223 | 1,490 |
| Operating Cash Flow | $5,831 | $4,646 | $3,789 | $-7,692 | $-8,719 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -356 | -876 | -470 | -322 | -315 |
| Net Acquisitions | N/A | N/A | 383 | 6,528 | N/A |
| Investing Cash Flow | $-356 | $-876 | $-87 | $6,206 | $-315 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,000 | N/A |
| Debt Issued | N/A | N/A | N/A | 1,000 | 17,000 |
| Debt Repayment | -4,400 | -5,600 | -2,500 | N/A | -8,236 |
| Common Stock Issued | N/A | N/A | N/A | 108 | 335 |
| Common Stock Repurchased | -18 | -46 | N/A | -108 | N/A |
| Other Financing Activity | -13 | -161 | -2,532 | 0 | -123 |
| Financing Cash Flow | $-4,431 | $-5,807 | $-5,032 | $3,000 | $8,976 |
| Beginning Cash Position | 1,461 | 3,498 | 4,828 | 3,314 | 3,372 |
| End Cash Position | 2,505 | 1,461 | 3,498 | 4,828 | 3,314 |
| Net Cash Flow | $1,044 | $-2,037 | $-1,330 | $1,514 | $-58 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,831 | 4,646 | 3,789 | -7,692 | -8,719 |
| Capital Expenditure | -356 | -876 | -470 | -322 | -354 |
| Free Cash Flow | 5,475 | 3,770 | 3,319 | -8,014 | -9,073 |